Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains a therapeutic challenge in clinical oncology. Surgery is the only potentially curative treatment. However, the majority of PDAC patients present with locally advanced/unresectable or metastatic disease, where palliative multiagent chemotherapy is the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sylvia S. W., Dawson, Laura A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775272/
https://www.ncbi.nlm.nih.gov/pubmed/36551971
http://dx.doi.org/10.3390/biomedicines10123215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775272/
https://www.ncbi.nlm.nih.gov/pubmed/36551971
http://dx.doi.org/10.3390/biomedicines10123215

Ejemplares similares